Presidential Election Strains Nation’s Sleep Health, Impacting Nearly One in Five Adults

Summary: The National Sleep Foundation’s latest report reveals that nearly one in five US adults, around 45 million people, experienced worsened sleep during the 2024 presidential election. Those affected reported shorter weekend sleep durations and poorer overall sleep quality. The impact spanned all demographics and was consistent across political affiliations. Experts emphasize the importance of addressing…

Read More

Americans Report Sleeping More During Winter as Mood Declines

Summary: A recent survey by the American Psychiatric Association shows that, during winter, 41% of Americans report sleeping more, with many experiencing declines in mood and increased fatigue. The impacts of seasonal time changes and shorter daylight hours are felt most significantly among women and Midwesterners, with common coping mechanisms including social connections and more…

Read More

Tiny Transitions Launches ‘Pay What You Can’ Sleep Training Model

Summary: Tiny Transitions has introduced Sleep Steps, a sleep training program offering a “pay what you can” model to ensure that all parents, regardless of financial means, can access sleep coaching for their children. The program includes tailored sleep education for newborns, infants, and toddlers, along with weekly live sessions led by founder Courtney Zentz…

Read More

Happy Ring Maker and EnsoData Offer Home Sleep Testing Solution

Summary: Happy Health and EnsoData have partnered to offer an at-home solution for diagnosing sleep apnea through the wearable Happy Ring. Utilizing EnsoSleep PPG, an FDA-cleared software as a medical device (SaMD), the ring delivers clinical-grade sleep monitoring and enables patients to obtain a diagnosis and start personalized care within three days. The collaboration aims…

Read More

Takeda’s Late-Stage Trial of TAK-861 for Narcolepsy Type 1 Underway

Summary: Takeda has initiated a phase 3 trial of TAK-861, an oral orexin receptor 2 agonist, for narcolepsy type 1, marking progress in its late-stage pipeline. Phase 2b results showed that TAK-861 significantly improved wakefulness and reduced symptoms in narcolepsy patients, with further R&D updates expected at Takeda’s R&D Day in December. Takeda’s first-half fiscal…

Read More

New Sensor Targets Early-Stage Drowsiness to Prevent Driver Collisions

Summary: Netradyne has introduced a third-generation AI-driven driver monitoring system that detects early-stage drowsiness in drivers and provides real-time alerts to reduce collision risks. The system uses sensors to monitor micro-behaviors, such as eye closure patterns, and integrates outward-facing cameras to assess road behaviors like lane departures, offering a comprehensive approach to drowsy driving prevention.…

Read More